Evidence map›Paper›PMID 32260464›Full record

ArticleMaterials (Basel, Switzerland)2020

Effects of Platelet-Rich Fibrin on Hard Tissue Healing: A Histomorphometric Crossover Trial in Sheep.

Esra Ondur, Nilufer Bolukbasi Balcioglu, Merva Soluk Tekkesin, Ozlem Guzel, Selim Ersanli

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Esra OndurDepartment of Oral Implantology, Faculty of Dentistry, Istanbul University, Istanbul 34093, Turkey.
Nilufer Bolukbasi BalciogluDepartment of Oral Implantology, Faculty of Dentistry, Istanbul University, Istanbul 34093, Turkey.
Merva Soluk TekkesinDepartment of Tumor Pathology, Institute of Oncology, Istanbul University, Istanbul 34093, Turkey.ORCID 0000-0002-7178-3335
Ozlem GuzelDepartment of Surgery, Veterinary Faculty, Istanbul University, Istanbul 34320, Turkey.
Selim ErsanliDepartment of Oral Implantology, Faculty of Dentistry, Istanbul University, Istanbul 34093, Turkey.ORCID 0000-0001-8911-3885
Istanbul University · TRIstanbul University-Cerrahpaşa · TR

Funding

Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi 18898
6 · The paper itself

Abstract

Bone defects lead to aesthetic and functional losses, causing dental rehabilitation to be more difficult. The objective of this work is to histologically assess the hard tissue healing of bone defects filled with platelet-rich fibrin (PRF) alone or as an adjuvant for mixing with and covering anorganic bovine bone (ABB), compared to ABB covered with a resorbable collagen membrane (CM). This study was designed as a crossover animal study. Four 5-mm tibia defects, 5 mm apart from each other, were surgically created on the tibias of 6 sheep. The defects were randomly filled with ABB + CM; PRF alone; ABB+PRF; or were left empty. The animals were euthanized on days 10, 20, and 40 post-operatively. No group showed any signs of bone necrosis. Inflammation was observed in 2 control and 3 test defects with no statistically significant difference between groups at each time point. The ABB + CM and ABB + PRF groups experienced the highest bone regeneration ratios. No differences between the empty-defect and PRF groups were observed in regard to bone regeneration. No statistical difference was observed between the ABB+PRF and ABB + CM groups in regard to bone regeneration and the amount of residual graft material at each time point. The use of PRF should be preferred due to its autogenous origin, low cost, and ease of use.

Indexed as

anorganic bovine bonebone augmentationhistological analysisplatelet rich fibrin

Identifiers

PMID32260464
PMCPMC7178662
OpenAlexW3014203486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.